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Background: Mitochondrial dysfunction has been implicated in neuronal apoptosis associated with neurodegenerative
diseases such as Huntington’s disease (HD). Animals that are administered 3-nitropropionic acid (3-NP), a mitochondrial
toxin that specifically inhibits complex II of the mitochondrial electron transport chain, manifest HD-like symptoms.
Methods: Psoralea corylifolia Linn seed extracts against 3-NP induced mitochondrial dysfunction in cultured rat
pheochromocytoma (PC12) cells, which are used for neurobiological studies.
Results: In this study showed that 3-NP-treated PC12 cells had decreased ATP levels, lower cellular oxygen
consumption, and reduced mitochondrial membrane potential than those of untreated PC12 cells. Psoralea
corylifolia Linn seed extracts stimulated mitochondrial respiration with uncoupling and induced an increased
bioenergetic reserve capacity. Furthermore, PC12 cells pretreated with P. corylifolia Linn seed extracts significantly
attenuated 3-NP-induced cell death, reduced ATP levels, and lowered the mitochondrial membrane potential.
Conclusions: These results demonstrate that P. corylifolia Linn seed extracts have a significant protective effect
against 3-NP induced cytotoxicity. Thus, our results indicate that P. corylifolia Linn seed extracts may have potential
applications as therapeutic agents for treating neurodegenerative disease.
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Psoralea corylifolia Linn is an herbaceous legume found
in India, China, and Korea, and it is commonly used in
traditional Chinese medicine [1]. P. corylifolia extracts have
been shown to possess several therapeutic properties,
including anti-tumor, anti-inflammatory, and radiomo-
dulatory properties, and have been shown to alleviate
osteoporosis in rats [2-5]. A previous study showed that
Δ3-2-hydroxybakuchiol isolated from P. corylifolia has
dopaminergic neuroprotective effects in vitro and has
antiparkinsonian-like effects in vivo [6]. Previous mouse
model studies have shown that P. corylifolia seed extract
components, psoralidin and furocoumarins, possess potent
anti-depressant properties [7-9].* Correspondence: mylee@kiom.re.kr
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unless otherwise stated.3-nitropropionic acid (3-NP) is a specific inhibitor
of mitochondrial respiratory complex II and can cause
HD -like symptoms in animals upon ingestion [10]. A
previous study showed that complex II inhibition by
3-NP resulted in mitochondrial fragmentation and
neuronal cell death via N-methyl-D-aspartate and reactive
oxygen species (ROS)-dependent pathways [11].
Brain neuron cells have higher sensitivity to oxidative
stress than other cells owing to their dependence on oxi-
dative phosphorylation as the primary energy source
[12]. Mitochondria play an important role in apoptosis
and neuronal degeneration. Due to the constant exposure
to high levels of energy and oxygen, mitochondria are
vulnerable to oxidative stress damage. Mitochondrial
electron leakage causes oxidative stress that can lead to
cell death. The mechanisms underlying oxidative damage-
induced neuronal death are poorly understood, and
whether mitochondrial defects are the primary cause of
toxicity or a secondary response to the damage remainsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Im et al. BMC Complementary and Alternative Medicine 2014, 14:370 Page 2 of 8
http://www.biomedcentral.com/1472-6882/14/370unknown [13]. However, impaired respiratory chain
activity or failure of mitochondrial function has been
implicated in the pathogenesis of several mitochondrial
disorders including neurodegenerative disorders [14].
Cell respiratory capacity declines with age, and this
decline is exaggerated in neurodegenerative mitochondrial
diseases. Mitochondria integrate extracellular signals, carry
out essential cellular functions, and determine neuronal
survival and death. Since, mitochondrial metabolism is
recognized as the primary source of ROS, mitochondrial
biogenesis is expected to increase oxidative stress in
neurons [15]. A previous study showed that a respiratory
reserve could provide a valuable therapeutic target for treat-
ing mitochondrial disorders and developing pharmacologic
approaches that tap into this respiratory reserve could
prove useful for treating neurodegenerative disorders [16].
In this study, we investigated the neuroprotective effect
of P. corylifolia seed extracts against 3-NP induced mito-
chondrial dysfunction in cultured rat pheochromocytoma
(PC12) cells, which are widely used for neurobiological
studies. We particularly studied the impact of P. corylifolia




3-NP, oligomycin, and rotenone were purchased from
Sigma (St. Louis, MO, USA). RPMI 1640 and fetal bovine
serum (FBS) were purchased from Gibco BRL (Grand
Island, NY). CellTiter Aqueous One Solution Cell prolifer-
ation assay (MTS) kits were purchased from Promega
Co. (Madison, USA). A luminescence ATP detection kit
(PerkinElmer, Waltham, MA, USA) and JC-1 mitochondrial
membrane potential detection kit (Biotium, Hayward, CA)
were used. Mitotracker®, Image-iT live green ROS detection
kit and MitoSOX™, Annexin-V, and propidium iodide
(PI) double staining kit were purchased from Invitrogen
Molecular Probes (San Diego, CA). XF-24 cell culture
microplates, extracellular flux assay kits, XF calibrant,
and XF assay medium were purchased from Seahorse
Bioscience (Billerica, MA).
Preparation of P. corylifolia seed extracts
P. corylifolia seed was purchased from Kwangmyungdang
Medicinal herbs (Ulsan, Korea). A voucher specimen
(KIOM111930, KIOM211930) has been deposited at
the herbarium of the Department of Aging Research
Lab., Korea Institute of Oriental Medicine, South Korea.
Aqueous extracts of P. corylifolia seed were prepared by
300 g of powdered plant material was mixed with 3 L of
distilled water in a flask and sonicating for 2 h. The
process was repeated three times. The suspension was
lyophilized of water extract. A 80% ethanol extract was
prepared by sonicating the dried ground powder suspendedin 80% ethanol solvent (v/v% in water) and the suspension
was processed as described for the aqueous extract.
Cell viability
PC12 cells (Korean Cell Line Bank, Korea) were cultured
in RPMI 1640 with 10% fetal bovine serum (FBS) at
37°C with 5% CO2. PC12 cells were plated at a density
of 1 × 104 cells/well with 200 μl RPMI 1640 containing
10% FBS in a 96-well collagen IV-coated plates and
were incubated at 37°C for 24 h. P. corylifolia seed
extracts prepared with water (PCWE) and with 80%
ethanol (PCEE) added to the cell culture plates followed by
incubation at 37°C for 24 h. Cell viability was determined
by performing an MTS test that assesses bioreduction
of MTS to formazan. The plates were assayed at 490 nm
by using a microplate fluorometer (Molecular Devices,
Sunnyvale, CA, USA). For determining the protective
effects of the extract in rotenone-induced PC12 cells,
samples of various concentrations were treated in a 96-well
collagen IV-coated plate at 24 h after adding 25 μM of
3-NP. After 3 h, the medium was removed and the
MTS assay was performed to assess the cell viability.
ATP measurement
Various concentrations of extracts were added to cells
in a 96-well white plate for 1 h before adding 25 μM of
3-NP and incubating for 3 h. Total cellular ATP content
was determined by using a luminescence ATP detection kit
and a in accordance with the manufacturer’s instructions
(PerkinElmer, Waltham, MA, USA). The total cellular
ATP content was determined by running an internal
standard and expressed as the percentage of untreated
cells (control).
XF-24 metabolic flux analysis
Oxygen consumption rate (OCR) was measured with a
Seahorse XF24 Extracellular Flux Analyzer (Seahorse
Bioscience, Billerica, MA). PC12 cells were seeded in
Seahorse XF-24 plates at a density of 5 × 104 cells/well.
Cells were treated with the sample in a 96-well white
plate 24 h before adding 25 μM of 3-NP. On the day of the
metabolic flux analysis, cells were switched to unbuffered
DMEM (DMEM base medium supplemented with 25 mM
glucose, 2 mM sodium pyruvate, 31 mM NaCl, 2 mM
GlutaMax, pH 7.4) and incubated at 37°C in an incubator
with no CO2 for 1 h. Three readings were taken after each
addition of mitochondrial inhibitor before injection of the
subsequent inhibitors. The mitochondrial inhibitors used
were ATP synthase inhibitor oligomycin (final concen-
tration: 1 μg/ml), the proton ionophore carbonylcyanide
p-trifluoromethoxyphenylhydrazone (FCCP; final concen-
tration 1 μM), and complex I inhibitor rotenone (final
concentration, 1 μM). Mitochondrial function parame-
ters were determined using mitochondrial inhibitors as
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mitochondrial function parameters, including basal respir-
ation, ATP turnover rate, proton leak, and maximal and
spare respiratory capacity. OCR was automatically calcu-
lated and recorded using the Seahorse XF-24 software.
Mitochondrial membrane potential
Cells were treated with samples in a 96-well white plate
for 24 h before adding 25 μM of 3-NP. MMP of PC12 cells
was measured by using a JC-1 mitochondrial membrane
potential assay kit (Biotium, Hayward, CA, USA) according
to the manufacturer’s instructions. The plates were then
incubated at 37°C for 20 min after the addition of
100 μl of 1 × JC-1 reagent into the wells. Red fluorescence
(excitation, 550 nm; and emission, 600 nm) and green
fluorescence (excitation, 485 nm and emission, 535 nm)
were determined using a Softmax Pro 5 fluorescence plate
reader (Molecular Devices, Sunnyvale, CA, USA). The
ratio of red to green fluorescence of dead cells and of
cells undergoing apoptosis is lower than that of the
healthy cells. For confocal microscope analysis, 1× JC-1
was added to treated cells and cells were incubated for
15 min at 37°C. Cells were imaged using a confocal
microscope (FV10i-LIV, Olympus, Tokyo, Japan). In
live non-apoptotic cells, mitochondria appeared red fol-
lowing aggregation of the JC-1 reagent. The excitation
of the red aggregates occurred at 559 nm and emission
was at 570–620 nm. In both the apoptotic cells and
dead cells, the dye remained in its monomeric form
and appeared green with excitation at 473 nm and
emission at 490–540 nm.
Mitochondrial superoxide
MitoSOX™ Red reagent was used for determining the
superoxide levels. MitoSOX™ does not react with ROS
and reactive nitrogen species within the cell, but it
selectively targets the mitochondria after permeating the
cells and rapidly reacting with the superoxides within
the mitochondrial matrix. Varying concentrations of sam-
ples were added to the cells plated in the 96-well white
plate 1 h before adding 25 μM of 3-NP for 3 h. Cells
were incubated with 5 μM MitoSOX™ Red for 20 min
at 37°C. MitoSOX™ Red has excitation/emission max-
ima of approximately 510/580 nm and the fluorescence
was measured by using the fluorescence plate reader
Softmax Pro 5 (Molecular Devices). A confocal micro-
scope (Olympus) was used for visual analysis of the cells.
Confocal microscopy analysis
PC12 cells were plated at a density of 5 × 104 cells on a
chamber slide. Cells were treated with samples at con-
centrations that ranged between 10–100 μg/ml for 24 h
before adding 25 μM of 3-NP. Cells were incubated for
45 min with 10 μM Mitotracker® Red and 1 μg/ml 4′,6-diamidino-2-phenylindole (DAPI) for detecting the mito-
chondria. Cells were visualized under a confocal micro-
scope (Olympus) and the fluorescence emission and
excitation was at 598 nm and 578 nm, respectively. DAPI
fluorescence was determined at an excitation wavelength
of 359 nm, and emission was detected at 461 nm.
Statistics
All data are expressed as mean ± standard deviation of at
least three independent experiments and analyzed by
one-way ANOVA and by multiple comparisons that
were performed by using the Student’s t-test. A p-value
of less than or equal to 0.05 was considered significant.
Results
Protective effect of PCWE and PCEE on 3-NP treated
PC12 cells
In this study, extraction yield of PCWE was 20.6% and
PCEE was 20.4%. We first examined the cytoprotective
effect of the sample against 3-NP induced cell death by
using MTS assay. The dose of 3-NP and the exposure
period to 3-NP that reduce the cell viability to 50% were
determined by using various 3-NP concentrations that
ranged between 10 μM to 1 mM (data not shown). The
data indicated that PC 12 cells treated with 25 μM 3-NP
for 3 h had cell viability of 54.1% as compared to the cell
viability of 100% of the control cells. Pretreatment with
PCWE for 24 h followed by 3-NP exposure resulted in
higher viability (viability of triplicates: 69.0%, 72.6%, and
73.7%) than that of 3-NP exposed PC12 cells that were not
pretreated with PCWE. Furthermore, pretreatment with
PCEE for 24 h followed by 3-NP exposure also resulted in
higher cell viability (viability of triplicates: 72.6%, 77.2%,
and 81.1%) than that of 3-NP exposed PC12 cells that
were not pretreated with PCEE (Figure 1A).
Effects of PCWE and PCEE on total cellular ATP levels
To determine whether the samples had an impact on
energy production, we measured ATP concentrations
by using the ATP lite assay kit. The cellular ATP levels of
3-NP treated cells after 3 h incubation were significantly
decreased (59.8%) from those of the control cells (100%).
As shown in Figure 1B, the ATP levels of 3-NP treated
group were lower than those of the sample-pretreated
group.
Bioenergetics analysis and mitochondrial function test
Seahorse cellular bioenergetic analyzer was used to examine
the effects of PCWE and PCEE on mitochondrial respir-
ation and cellular glycolysis in PC12 cells. Oligomycin
A (complex V inhibitor), FCCP (uncoupler), and rotenone
(complex I inhibitor) were sequentially applied to deter-
mine the action of PCWE and PCEE on the electron
Figure 1 Protective effect of P. corylifolia seed extracts. (A) Protective effect of P. corylifolia seed water extract (PCWE) and P. corylifolia seed
ethanol extract (PCEE) pretreatment in 3-nitropropionic acid (3-NP) treated pheochromocytoma (PC12) cells. Data are reported as a percentage of
control cell viability. (B) Effects of PCWE and PCEE on total cellular ATP levels. ATP levels were measured by using ATPliteTM luminescence-based
assay. Data are reported as a relative percentage of control. * p < 0.05, ** p <0.01, and *** p <0.001.
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was increased by the pretreatment of PCWE (Figure 2A)
and PCEE (Figure 2B). We found that 3-NP treatment
decreased the mitochondrial OCR to 38 pMol/min com-
pare to control cells (129 pMol/min) of the basal level
(Figure 2C) that indicate 3-NP exposure inhibited basal
mitochondrial respiration. However, 3-NP treated cells
that were pretreated with either 100 μg/ml PCWE or
PCEE to prevent intracellular acidification had OCR of
189 pMol/min and 201 pMol/min, respectively. Thus, the
extract pretreated cells had mitochondrial OCR that were
comparable to that of the control cells that were not
exposed to the extracts or 3-NP. In a previous study, the
coupling efficiency and spare respiratory capacity under
these conditions were estimated by using oligomycin and
FCCP, respectively [17]. In this study, after measurementof the basal OCR, oligomycin was injected into all samples
to inhibit the ATP synthase (complex V). PC12 cells that
were pretreated with 3-NP showed a substantial decrease
in OCR. However, the OCR of oligomycin-treated cells
that were also pretreated with PCWE and PCEE can be
ascribed to both proton leakages across the mitochondrial
membrane and to the utilization of the mitochondrial
membrane potential for ion or substrate transport. To
determine the maximal OCR that the cells can sustain,
the proton ionophore (uncoupler) FCCP was injected
after oligomycin treatment. FCCP addition resulted in
stimulation of OCR due to increased proton permeability
of the mitochondrial inner membrane that resulted in
an OCR that was unconstrained by the mitochondrial
membrane potential. Thus, the FCCP-treated cell mito-
chondrial respiration reached maximal capacity and
Figure 2 Mitochondrial respiration of PC12 cells Oxygen consumption rate (OCR) was monitored in control cells, 3-NP treated cells,
and in cells that were pretreated with PCWE or PCEE followed by 3-NP treatment. (A) Cells were pretreated with PCWE at concentrations
of 10, 50, and 100 μg/ml for 24 h followed by 25 μM 3-NP treatment for 3 h. (B) Cells were pretreated with PCEE at concentrations of 10, 50, and
100 μg/ml for 24 h followed by treatment with 25 μM 3-NP for 3 h. (C) Basal respiration was calculated from OCR. Vertical lines indicate time of
addition of mitochondrial inhibitors A: oligomycin (1 μg/ml), B: FCCP (1 μM), or C: rotenone (1 μM). * p < 0.05, and ** p <0.01.
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injected lastly to inhibit electron flux through complex
I, which causes OCR suppression.Mitochondrial membrane potential
We next examined the effect of PCWE and PCEE treat-
ment on 3-NP-induced cell mitochondrial membrane
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ing. The red signal of 3-NP significantly decreased, and
consequently, the red/green signal ratio also decreased
as indicated by JC-1 staining (Figure 3). 3-NP increased
the mitochondrial membrane potential in the initial
stages of the experiment as indicated by the alterations
in JC-1 dye aggregation. 3-NP treatment for 3 h caused
a significant reduction in JC-1 ratio, as indicated by the
depolarized MMP, and inhibited a significant increase in
MMP with 10 μg/ml PCEE treatment, as indicated by
88.7% increase in red JC-1 fluorescence (Figure 3A). As
shown in figure 3B, cells pretreated with 3-NP had lower
red signal intensity than the control cells. The MMP of
PC12 cells that were treated with PCWE or PCEE
showed a gradual recovery, as indicated by the reappear-
ance of red-stained mitochondria.
Confocal microscopy analysis of mitochondrial
superoxide levels and mitochondria
For detection of mitochondrial superoxide, we used Mito-
SOX™ Red mitochondrial superoxide reagent. Cellular
MitoSOX™ fluorescence intensities were assessed by
confocal microscopy (Figure 4A). 3-NP treated cells hadFigure 3 Mitochondrial membrane potential (MMP) of the PC12 cells
(A) Red fluorescence intensity (excitation, 550 nm; emission, 600 nm) and g
were determined by using a fluorescence plate reader. (B) Confocal image
of the control. * p < 0.05, and ** p <0.01.higher mitochondrial superoxide production signals than
that of the PCWE or PCEE pretreated cells. These results
show that PCWE and PCEE protected the cells from
3-NP-induced mitochondrial superoxide production.
MitoTracker ®, a red fluorescent dye, was used to stain
PC12 cell mitochondria. Confocal microscope analysis
revealed that the stained mitochondria in control cells
were evenly distributed around the cell (Figure 4B).
However, the 3-NP induced cells showed low red fluores-
cence intensity in mitochondria, indicating depolarization
of the inner mitochondrial membrane.
Discussion
P. corylifolia extracts have been shown to possess several
therapeutic properties including neuroprotective effects.
In previous researches, in vitro dopaminergic neuropro-
tective and in vivo antiparkinsonian-like effects of Delta
3,2-hydroxybakuchiol isolated from Psoralea corylifolia
was investigated [18]. Also, seeds of P. corylifolia was found
to strongly inhibit dopamine uptake by dopamine trans-
porter heterogeneously expressed cells and noradrenaline
uptake by noradrenaline transporter [19].measured by JC-1 as an indicator of mitochondrial function.
reen fluorescence intensity (excitation, 485 nm; emission, 535 nm)
s show JC-1 fluorescence (60 × 3.5). Data are reported as a percentage
Figure 4 Confocal microscopy analysis of mitochondrial superoxide production and mitochondria. (A) MitoSOX™ Red staining followed
by confocal microscopy analysis (60 × 3.5) was used to measure mitochondrial superoxide production. (B) Mitotracker® Red fluorescence stained
mitochondria. Merged images of cells stained with Mitotracker® Red with 4',6-diamidino-2-phenylindole (DAPI) blue fluorescence stained cells
were used to determine colocalization by using confocal microscopy (10 × 3.5). All data are reported as a percentage of control. * p < 0.05.
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chondrial metabolism impairment that leads to increased
ROS and mitochondrial dysfunction. The mechanisms
underlying HD development have been associated with
mitochondrial dysfunction, which plays a critical role in
this process. The HD brain tissues have decreased levels
of electron transport chain complexes II and III [20,21].
Therefore, mitochondrial respiratory complex II inhibition
may play an important role in HD. Administration of
3-NP, a complex II inhibitor, induces symptoms that are
associated with neurodegenerative diseases such as HD.
Animals that were orally administered 3-NP developed
HD-like neuropathology [22,23]. 3-NP treatment induced
cell death both by apoptosis and necrosis in PC 12 cells.
One of the modes of action of 3-NP-mediated toxicity
involves energy depletion by inhibition of the complex IIof the electron transport chain. Neuronal cells maintain
a bioenergetic capacity that is sufficient to meet physio-
logical energy demands, with a reserve or spare capacity
that can be utilized by the cells under stress [17]. The
neuroprotective benefits of P. corylifolia Linn seed could
be partially attributed to 3-NP-induced enhancement of
mitochondrial function. Extracellular flux analysis allows
determination of oxygen consumption and extracellular
acidification in cells. 3-NP inhibited OCR, indicating
mitochondrial dysfunction. P. corylifolia Linn seed ex-
tracts treatment increased the mitochondrial respiratory
capacity as indicated by the OCR value. The basal OCR
was decreased in 3-NP treated cells and was increased in
pretreated extracts and 3-NP-exposed cells.
Measurement of MMP and mitochondrial superoxide
generation further demonstrated the impact of P. corylifolia
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Linn seed extract treatment increased the MMP, correlated
with the capacity for ATP production, and decreased the
mitochondrial superoxide generation. Furthermore, a previ-
ous study showed that inhibition of the electron transport
chain by 3-NP leads to the production of mitochondrial
superoxide and the disruption of mitochondrial respiration
caused by 3-NP results in the production of less ATP as
well as more ROS [24].
Conclusions
The results from this study suggest that P. corylifolia
Linn seed extracts induced production of ATP and
MMP and these decreased the mitochondrial superoxide
levels. These findings suggest that P. corylifolia Linn seed
could be potentially used as a therapeutic agent for
treating neurodegenerative diseases. Future studies for
identification of the active chemical moiety of the extracts
may serve as a starting point for developing neuroprotec-
tive therapeutics to treat neurodegenerative disease.
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